FST Mouse

Follistatin Mouse Recombinant
Shipped with Ice Packs
In Stock

Description

Genetic Characteristics of the Fst Gene

The Fst gene (Gene ID: 14313) is located on mouse chromosome 13 and encodes follistatin, a glycoprotein that binds and inhibits members of the TGF-β superfamily, particularly activin . Key features include:

PropertyDetail
SynonymsFS, activin-binding protein
Ensembl IDENSMUSG00000021765
Protein IsoformsFST315 (circulating), FST288 (tissue-bound), FST303 (gonad-specific)
Knockout PhenotypeEmbryonic lethality if all isoforms are deleted; FST288 alone supports development but causes infertility .

Protein Function and Mechanisms

Follistatin acts as a negative regulator of activin and BMP signaling, impacting processes such as:

  • Embryonic development: Critical for proper tissue morphogenesis, particularly in hair follicles and keratinocyte proliferation .

  • Muscle growth: Antagonizes myostatin (GDF-8), leading to increased muscle mass in transgenic mice .

  • Reproductive function: Modulates follicle-stimulating hormone (FSH) levels and ovarian folliculogenesis .

Developmental Studies

  • Mice lacking all Fst isoforms die during embryogenesis due to uncontrolled activin signaling .

  • Overexpression of FST288 in knockout mice rescues embryonic viability but results in defective spermatogenesis and ovarian function .

Muscle and Metabolic Phenotypes

InterventionOutcomeSource
Follistatin overexpression20–30% increase in muscle mass; improved strength in SMA models .
AAV-mediated FST deliveryReduced obesity-induced inflammation and protection from osteoarthritis in mice .

Behavioral and Cognitive Insights

While Fst itself is not directly linked to behavioral tests like the Forced Swim Test (FST), studies using reinforcement learning models in FST paradigms have revealed:

  • Chronic stress increases immobility time, reflecting altered cognitive processes (e.g., consequence sensitivity adaptation) .

  • Genetic background strongly influences baseline immobility and antidepressant response in FST .

Clinical and Therapeutic Relevance

  • Type 2 diabetes: Elevated follistatin levels correlate with insulin resistance and NAFLD risk .

  • Polycystic ovary syndrome (PCOS): Follistatin’s role in FSH regulation makes it a candidate biomarker .

  • Gene therapy: AAV vectors delivering Fst show promise for muscular dystrophy and inflammatory myopathies .

Limitations and Future Directions

  • Strain variability: Outbred strains (e.g., CD-1, Swiss) show more consistent responses to Fst manipulations than inbred strains .

  • Isoform-specific effects: Differential roles of FST288 vs. FST315 in circulation vs. tissue binding require further study .

Product Specs

Introduction
Follistatin, a single-chain gonadal protein, plays a crucial role in regulating follicle-stimulating hormone (FSH) release. It exists in two isoforms, FST317 and FST344, differing in amino acid count due to alternative splicing of precursor mRNA. Studies have revealed a potential link between follistatin and polycystic ovary syndrome (PCOS). Functioning as an activin antagonist, follistatin directly interacts with activin, effectively inhibiting the production and secretion of pituitary FSH.
Description
Recombinant Mouse Follistatin, produced in E.Coli, is a single, non-glycosylated polypeptide chain comprising 289 amino acids. With a molecular weight of 31.6kDa, it undergoes purification using proprietary chromatographic techniques.
Physical Appearance
White lyophilized powder, sterile filtered.
Formulation
Mouse Follistatin undergoes lyophilization in a buffer solution of 10mM Na₂PO₄ and 50mM NaCl, at a pH of 7.5.
Solubility
For reconstitution, it is recommended to dissolve the lyophilized Follistatin in sterile 18MΩ-cm H2O at a concentration not less than 100µg/ml. Further dilutions can be made using other aqueous solutions.
Stability
Lyophilized Follistatin remains stable at room temperature for up to 3 weeks. However, for extended storage, it is recommended to store desiccated below -18°C. Upon reconstitution, FST should be stored at 4°C for 2-7 days. For long-term storage, adding a carrier protein like 0.1% HSA or BSA is advisable. Avoid freeze-thaw cycles.
Purity
Purity exceeds 90.0% as assessed by SDS-PAGE.
Biological Activity
The ED₅₀, representing the dose required for 50% neutralization of 7.5ng/ml human Activin-A on MCP-11 cells, falls within the range of 0.13-0.19µg/ml.
Synonyms
Follistatin, FST, FS, Activin-binding protein, AL033346.
Source
Escherichia Coli.
Amino Acid Sequence
MGNCWLRQAK NGRCQVLTKT ELSKEECCST GRLSTSWTEE DVNDNTLFKW MIFNGGAPNC IPCKETCENV DCGPGKKCRM NKKNKPRCVC APDCSNITWK GPVCGLDGKT YRNECALLKA RCKEQPELEV QYQGRCKKTC RDVFCPGSST CVVDQTNNAY CVTCNRICPE PASSEQYLCG NDGVTYSSAC HLRKATCLLG RSIGLAYEGK CIKAKSCEDI QCTGGKKCLW DS.

Q&A

What are the standard dimensions and specifications for FST apparatus in mice?

The standard apparatus for mouse FST consists of cylindrical tanks made of transparent Plexiglas with dimensions of approximately 30 cm in height and 20 cm in diameter. Plexiglas is preferred over glass due to its durability during frequent movement and potential accidents. The water level should be maintained at 15 cm from the bottom and clearly marked to ensure consistent volume across test subjects .
The dimensions are specifically selected to prevent mice from touching the bottom of the tank with either their feet or tails during swimming. Additionally, the height must be sufficient to prevent escape. These parameters are critical as tank diameter and water depth can be adjusted to modify behavioral responses in experimental paradigms .
For efficient testing of multiple animals, it is recommended to have at least twice as many tanks as the number of mice being tested simultaneously, allowing one set to be filled while another is in use. This setup facilitates continuous testing without delays between subjects .

What behaviors should be scored during the mouse FST, and how are they defined?

When analyzing FST behavior, researchers must clearly differentiate between mobility and immobility. Immobility is typically defined as floating or making only the minimal movements necessary to keep the head above water. Mobility includes swimming (horizontal movement), climbing (vertical movement against the wall), and struggling behaviors .
The most significant source of variability between observers in FST analysis is the correct identification of mobility versus immobility. Therefore, inter-observer reliability testing is essential before data collection begins. In professional research settings, new observers first observe experienced scorers, then score under supervision, and finally analyze training videos until achieving high inter-observer correlation with experienced researchers .
Some modified protocols evaluate specific active behaviors separately, distinguishing between swimming (horizontal movement throughout the cylinder) and climbing (upward-directed movements against the walls). These distinctions can be particularly useful when evaluating different classes of antidepressants, as serotonergic and noradrenergic compounds may affect these behaviors differently .

How significant is inter-individual variability in the FST, and how can it be addressed in experimental design?

Inter-individual variability in FST behavior is a significant concern that can affect result interpretation. Even genetically identical mice from the same strain can show considerable variations in immobility duration in the absence of any treatment . This variability represents an important point of interest when interpreting FST results and can potentially interfere with consistent use of the test.
Research has shown that animals displaying specific behavioral profiles in the FST may also exhibit systematic differences in other behaviors, including ethanol intake, stress responses, and spatial memory performance. For example, "swim-test susceptible" rats (those showing reduced struggling and/or increased immobility) have been associated with high voluntary ethanol intake, enhanced stress-induced ethanol drinking, and poor performance on spatial memory tasks .
To address this variability, proper experimental design should include:

  • Adequate sample sizes based on power analysis

  • Balanced counterbalancing between variables

  • Equal representation of each treatment group in every FST session

  • Rotation of animals such that mice from each treatment group are placed in different tanks in each session

  • Consistent testing conditions including time of day, water temperature, and handling procedures

How do housing conditions and environmental factors affect mouse behavior in the FST?

Housing conditions significantly impact FST outcomes. Short or long-term isolation can modify immobility behavior in the mouse FST, with isolated rat weanlings showing increased immobility time compared to group-housed counterparts . Other environmental factors that influence FST results include:
Light conditions: Testing conducted during the dark phase of the circadian cycle may yield different results compared to testing during the light phase. Consistency in lighting conditions across experiments is essential.
Noise levels: Background noise can alter stress responses and consequently affect FST behavior. Testing should occur in sound-controlled environments with minimal disturbances.
Water temperature: This parameter should be carefully controlled (typically 23-25°C for mice) as it affects swimming behavior and metabolic responses.
Handling procedures: Prior handling of mice by researchers can influence stress responses and consequently FST outcomes. Consistent handling protocols should be established before testing .
To minimize variability, researchers should maintain sufficient distance from animals during testing and avoid movements or noises that might be noticed by the test subjects. The experimenter's presence should be consistent across all trials, as novel stimuli can alter stress responses and behavioral outcomes .

What role do age and sex play in FST outcomes, and how should these variables be considered in study design?

Age and sex represent critical biological variables that significantly influence FST outcomes. Developmental stage affects behavioral responses, with adolescent rodents often showing different immobility patterns compared to adults. Age-related changes in neurotransmitter systems, stress responsiveness, and motor capability can all contribute to these differences .
Sex differences in FST behavior are well-documented, with distinct patterns of immobility time between males and females. These differences may be influenced by gonadal hormones, neurobiological differences in stress response systems, and other sex-specific physiological factors. The estrous cycle in females can introduce additional variability, potentially requiring cycle-phase tracking in female subjects .
When designing FST studies, researchers should:

  • Use age-matched animals within specific developmental windows

  • Consider sex as a biological variable and either include both sexes or provide scientific justification for single-sex studies

  • Report the specific age and sex of animals used

  • When using females, consider monitoring estrous cycle phase

  • Avoid generalizing findings from one sex or age group to others without appropriate validation

How do genetic modifications or pharmacological manipulations affect baseline FST behavior?

Genetic modifications can substantially alter baseline FST behavior, necessitating careful experimental design and interpretation. When testing mice with novel genetic manipulations in the FST, researchers should first establish baseline behavioral characteristics before proceeding with experimental interventions. Comparisons should be made between genetically modified mice and their wild-type counterparts under identical testing conditions .
Pharmacological manipulations, particularly long-acting compounds, can establish new behavioral baselines that must be considered when interpreting FST results. Pre-treatment with certain drugs can alter neurotransmitter systems, stress responsivity, or motor function, potentially masking or enhancing effects of subsequent experimental manipulations .
The following considerations should guide research with genetically modified or pharmacologically treated mice:

  • Include appropriate control groups (wild-type littermates for genetic studies; vehicle-treated controls for pharmacological studies)

  • Characterize baseline behavior across multiple behavioral domains, not just the FST

  • Consider potential compensatory mechanisms in constitutive knockout models

  • For pharmacological studies, establish dose-response relationships and time courses

  • Be aware that some genetic backgrounds may interact with specific genetic modifications to produce unique behavioral phenotypes

How can researchers distinguish between true antidepressant effects and false positives due to general changes in activity?

  • Include parallel assessment of general locomotor activity (e.g., open field test) alongside the FST

  • Evaluate dose-dependent effects to identify potential non-specific stimulant effects at higher doses

  • Incorporate positive controls (established antidepressants) and negative controls (non-antidepressant psychotropics) when testing novel compounds

  • Consider analyzing specific active behaviors (swimming vs. climbing) rather than just immobility, as different classes of antidepressants can produce distinct patterns of active behaviors

  • Use complementary behavioral tests such as the tail suspension test to verify findings
    When analyzing FST data, it's important to remember that immobility time is just one measure, and the pattern of active behaviors can provide additional insights. For example, serotonergic antidepressants typically increase swimming behavior, while noradrenergic agents tend to increase climbing behavior in rats, potentially reflecting differential effects on neurotransmitter systems .

How should contradictory results in the FST be analyzed and interpreted?

Contradictory results in FST research are common due to methodological variations, strain differences, and environmental factors. When confronted with contradictory findings, researchers should systematically analyze potential sources of variation:

  • Methodological differences: Variations in water depth, tank dimensions, water temperature, testing duration, and scoring methods can all contribute to contradictory outcomes. For example, increasing water depth to 30 cm prevents rats from stabilizing through tail contact with the tank bottom, decreasing immobility time .

  • Strain-specific responses: Different strains can show opposite responses to the same manipulation. Long Evans rats display contradictory results in the FST compared to other strains - they are less immobile than Sprague-Dawley, Wistar, and Fisher 344 rats in a single 15-minute session, but don't show the typical increase in immobility during a second swim session .

  • Interaction effects: Treatment effects may interact with strain, sex, age, or housing conditions. For instance, WKY rats show blunted responses to serotonergic antidepressants but enhanced responses to noradrenergic compounds .
    Researchers can employ several strategies for handling contradictions:

  • Replicate experiments using identical methodology across multiple laboratories

  • Directly compare different strains within the same experiment

  • Employ complementary behavioral tests to verify findings

  • Use statistical methods designed to identify interaction effects

  • Consider advanced contradiction detection methods similar to those used in clinical literature analysis

What modifications to the standard FST protocol have been developed, and when should they be used?

Several modifications to the standard FST protocol have been developed to enhance sensitivity or address specific research questions:

  • Water depth modification: Increasing water depth to 30 cm for rats prevents stabilization through tail contact with the tank bottom, decreasing baseline immobility and potentially increasing sensitivity to antidepressant effects .

  • Single vs. two-session protocols: While the original Porsolt test uses two sessions (15 minutes followed by 5-6 minutes 24 hours later), many researchers now use a single 6-minute session, analyzing only the last 4 minutes. The single-session approach may be preferred when studying acute effects, while the two-session protocol may better model behavioral despair or learned helplessness .

  • Scoring modifications: Beyond measuring immobility time, some protocols distinguish between different active behaviors (swimming, climbing, diving) to provide more nuanced behavioral analysis. This approach is particularly useful when comparing different classes of antidepressants, which may differentially affect these behaviors .

  • Pre-test manipulations: Some protocols incorporate stress induction or other manipulations before the FST to model specific aspects of depression or to increase sensitivity to antidepressant effects .
    The choice of protocol modification should be guided by:

  • The specific research question being addressed

  • The pharmacological or genetic manipulation being studied

  • The mouse strain being used

  • The need to detect specific behavioral patterns beyond simple immobility

  • Compatibility with previous literature for comparison of results

What are the key ethical considerations when conducting the FST, and how can researcher minimize stress to animals?

The FST inevitably exposes animals to stress, raising important ethical considerations that researchers must address. While the test is widely used in depression research and drug screening, several approaches can minimize unnecessary stress:

  • Proper training: Ensure all personnel are thoroughly trained in proper handling techniques and test procedures. Inexperienced handlers can induce additional stress that affects both animal welfare and experimental outcomes .

  • Close monitoring: During the test, animals should be continuously monitored, especially when testing new strains or compounds with unknown effects on swimming behavior. While mice typically float well, some strains or treatments might impair this ability. Video monitoring allows researchers to intervene immediately if an animal shows signs of distress beyond the expected test response .

  • Temperature control: Water and room temperature should be carefully controlled to prevent hypothermia. Proper drying and warming of animals after testing is essential .

  • Test duration optimization: Limiting test duration to the minimum necessary for reliable results reduces stress exposure. Many protocols now use 6-minute tests with only the last 4 minutes analyzed, rather than longer exposures .

  • Sample size calculation: Proper statistical planning to determine minimum required sample sizes helps avoid unnecessary testing of additional animals. When possible, within-subjects designs may reduce the total number of animals needed .
    Institutional Animal Care and Use Committees typically require thorough justification for FST use, demonstration that alternatives have been considered, and evidence that procedures minimize distress while maintaining scientific validity.

What alternative approaches or complementary tests can be used alongside or instead of the FST?

While the FST remains widely used, several alternative or complementary approaches address some of its limitations:

  • Tail Suspension Test (TST): This test measures similar behavioral endpoints (immobility as a depression-like behavior) but eliminates the potential hypothermia associated with water immersion. The TST is often used as a complementary test to confirm FST findings, though some strains (particularly C57BL/6) may show tail-climbing behavior that complicates analysis .

  • Sucrose Preference Test: This test measures anhedonia (reduced ability to experience pleasure), another core symptom of depression. Animals are given a choice between regular water and sucrose solution, with reduced preference for the sweet solution indicating anhedonia. This test addresses different aspects of depression-like behavior than the FST and may be more sensitive to chronic stress effects .

  • Novel approaches: Various researchers are developing alternative behavioral tests that either reduce stress or measure different aspects of depression-like behavior. These include tests of effort-based decision making, cognitive bias assessment, and social interaction changes .

  • In vitro screening: For initial drug screening, cell-based assays targeting specific receptors or signaling pathways relevant to depression may reduce the need for in vivo testing, following the 3Rs principle (Replacement, Reduction, Refinement) .
    For comprehensive assessment of depression-like states or antidepressant effects, a battery approach using multiple complementary tests is often most informative, as each test captures different aspects of the complex behavioral and neurobiological changes associated with depression .

What statistical approaches are recommended for analyzing FST data, and how should outliers be handled?

FST data analysis requires careful statistical consideration to ensure valid interpretation of results. Recommended statistical approaches include:

  • Parametric vs. non-parametric tests: Immobility time data should be tested for normality before selecting appropriate statistical tests. While many researchers use parametric tests (t-tests, ANOVA) for FST data, non-parametric alternatives may be more appropriate when normality assumptions are violated .

  • Factorial designs: When investigating multiple factors (e.g., strain, treatment, sex), factorial ANOVA designs allow assessment of both main effects and interactions. Significant interactions often provide important insights that might be missed with simpler analyses .

  • Repeated measures approaches: For protocols involving multiple testing sessions or time-course analyses, repeated measures ANOVA or mixed-effects models can account for within-subject correlations .
    Outlier handling requires careful consideration:

  • Extreme values should be examined for potential recording errors or unusual animal behavior (e.g., diving, wall climbing)

  • Statistical outlier tests (e.g., Grubbs' test, modified z-scores) can be used to identify potential outliers objectively

  • Rather than automatic exclusion, outliers should be reported transparently with analyses presented both with and without outlier exclusion

  • Pre-established exclusion criteria should be determined before data collection begins
    Regardless of the statistical approach, researchers should report effect sizes alongside p-values to better characterize the magnitude of observed effects, particularly important for translational implications .

How can researchers improve reproducibility and translational value of FST studies?

Enhancing reproducibility and translational relevance of FST studies requires systematic attention to methodological details and reporting standards:

Product Science Overview

Structure and Function

Follistatin is a glycoprotein that exists in multiple isoforms, primarily Follistatin-288 (FS-288) and Follistatin-315 (FS-315), which differ in their ability to bind heparin and cell surface proteoglycans. The recombinant mouse Follistatin used in research is often derived from the Spodoptera frugiperda (Sf 21) cell line using baculovirus expression systems .

The primary function of Follistatin is to bind and neutralize members of the TGF-β superfamily, particularly activins. By inhibiting activins, Follistatin regulates various physiological processes, including muscle growth, inflammation, and reproductive functions .

Biological Significance
  1. Muscle Growth: Follistatin has gained significant attention for its role in muscle development. It inhibits myostatin, a negative regulator of muscle growth, thereby promoting muscle hypertrophy. This property makes Follistatin a potential therapeutic target for muscle-wasting diseases.

  2. Reproductive Health: Follistatin is involved in the regulation of reproductive hormones. By inhibiting activins, it modulates the secretion of follicle-stimulating hormone (FSH), which is essential for reproductive health.

  3. Inflammation and Wound Healing: Follistatin also plays a role in modulating inflammatory responses and promoting wound healing. Its ability to bind and neutralize activins helps in controlling inflammation and tissue repair processes.

Applications in Research

Recombinant mouse Follistatin is widely used in research to study its various biological functions and potential therapeutic applications. It is utilized in experiments involving muscle growth, reproductive health, and inflammatory responses. The recombinant protein is typically produced in a carrier-free form to avoid interference from other proteins, ensuring accurate and reliable results in experimental settings .

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2024 Thebiotek. All Rights Reserved.